Source: Health Products Regulatory Authority (IE) Revision Year: 2020 Publisher: Essential Pharma (M) Limited, Vision Exchange Building, Triq it-Territorjals, Zone 1, Central Business District, Birkirkara, CBD 1070, Malta
Slow K 600mg Prolonged-release Coated Tablets.
Pharmaceutical Form |
---|
Coated tablet. Pale orange, round, biconvex, polished sugar-coated tablets. |
One sugar-coated tablet contains 600 mg potassium chloride as active substance equivalent to 8 mmol potassium ion (K+).
Excipients: Each tablet contains 96.4mg sucrose.
For a full list of excipients, see section 6.1, list of excipients.
Active Ingredient | Description | |
---|---|---|
Potassium chloride |
Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism. |
List of Excipients |
---|
Tablet Core: Cetostearyl alcohol Tablet Coating: Spray-dried acacia |
Securitainer (PP) in packs of 500.
Essential Pharma (M) Limited, Vision Exchange Building, Triq it-Territorjals, Zone 1, Central Business District, Birkirkara, CBD 1070, Malta
PA22644/002/001
Date of first authorisation: 17th February 1977
Date of last renewal: 17th February 2007
Drug | Countries | |
---|---|---|
SLOW K | Brazil, Ireland, Malta, Netherlands |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.